益生菌
Probiotics
共 8 個適應症評級
白話說:有初步證據,但研究規模還小,別當成定論。
證據分數 67 分(滿分 100) · 發布狀態:可參考,但附帶但書
- US FDA 態度:持保留
展開原文引用
「FDA has not approved any probiotic product for use as a drug or biological product in infants of any age」 - EU EFSA 態度:不支持
展開原文引用
「a cause and effect relationship had not been established between the consumption of a combination of bacterial strains and reduction of gastro-intestinal discomfort」 - UK NHS 態度:持保留
展開原文引用
「There's some evidence that probiotics may be helpful in some cases, such as helping to ease some symptoms of irritable bowel syndrome (IBS). But there's little evidence to support many health claims made about them.」
評級由多源健康證據引擎彙整(FDA/EFSA/NHS/TFDA/WHO/PubMed/NIH ODS 等多個官方與權威來源)。 產製日期 2026-06-09 · 版本 v10。本評級僅供衛教參考,不取代醫師診斷與處方。 · 查看此成分的完整評級 · 📊 證據資料庫原始頁面
白話說:目前沒有可靠的人體研究,無法下定論。
證據分數 65 分(滿分 100) · 發布狀態:證據尚不足以下判斷
- US FDA 態度:持保留
展開原文引用
「FDA has not approved any probiotic product for use as a drug or biological product in infants of any age」 - EU EFSA 態度:不支持
展開原文引用
「a cause and effect relationship had not been established between the consumption of a combination of bacterial strains and reduction of gastro-intestinal discomfort」 - UK NHS 態度:持保留
展開原文引用
「There's some evidence that probiotics may be helpful in some cases, such as helping to ease some symptoms of irritable bowel syndrome (IBS). But there's little evidence to support many health claims made about them.」
評級由多源健康證據引擎彙整(FDA/EFSA/NHS/TFDA/WHO/PubMed/NIH ODS 等多個官方與權威來源)。 產製日期 2026-06-01 · 版本 v32。本評級僅供衛教參考,不取代醫師診斷與處方。 · 查看此成分的完整評級 · 📊 證據資料庫原始頁面
白話說:有初步證據,但研究規模還小,別當成定論。
證據分數 63 分(滿分 100) · 發布狀態:可參考,但附帶但書
- US FDA 態度:持保留
展開原文引用
「FDA has not approved any probiotic product for use as a drug or biological product in infants of any age」 - EU EFSA 態度:不支持
展開原文引用
「a cause and effect relationship had not been established between the consumption of a combination of bacterial strains and reduction of gastro-intestinal discomfort」 - UK NHS 態度:持保留
展開原文引用
「There's some evidence that probiotics may be helpful in some cases, such as helping to ease some symptoms of irritable bowel syndrome (IBS). But there's little evidence to support many health claims made about them.」
評級由多源健康證據引擎彙整(FDA/EFSA/NHS/TFDA/WHO/PubMed/NIH ODS 等多個官方與權威來源)。 產製日期 2026-06-09 · 版本 v9。本評級僅供衛教參考,不取代醫師診斷與處方。 · 查看此成分的完整評級 · 📊 證據資料庫原始頁面
白話說:證據還很薄弱,不足以當成有效的療法。
證據分數 61 分(滿分 100) · 發布狀態:可參考,但附帶但書
- US FDA 態度:持保留
展開原文引用
「FDA has not approved any probiotic product for use as a drug or biological product in infants of any age」 - EU EFSA 態度:不支持
展開原文引用
「a cause and effect relationship had not been established between the consumption of a combination of bacterial strains and reduction of gastro-intestinal discomfort」 - UK NHS 態度:持保留
展開原文引用
「There's some evidence that probiotics may be helpful in some cases, such as helping to ease some symptoms of irritable bowel syndrome (IBS). But there's little evidence to support many health claims made about them.」
評級由多源健康證據引擎彙整(FDA/EFSA/NHS/TFDA/WHO/PubMed/NIH ODS 等多個官方與權威來源)。 產製日期 2026-06-09 · 版本 v10。本評級僅供衛教參考,不取代醫師診斷與處方。 · 查看此成分的完整評級 · 📊 證據資料庫原始頁面
白話說:有初步證據,但研究規模還小,別當成定論。
證據分數 60 分(滿分 100) · 發布狀態:可參考,但附帶但書
- US FDA 態度:持保留
展開原文引用
「FDA has not approved any probiotic product for use as a drug or biological product in infants of any age」 - EU EFSA 態度:不支持
展開原文引用
「a cause and effect relationship had not been established between the consumption of a combination of bacterial strains and reduction of gastro-intestinal discomfort」 - UK NHS 態度:持保留
展開原文引用
「There's some evidence that probiotics may be helpful in some cases, such as helping to ease some symptoms of irritable bowel syndrome (IBS). But there's little evidence to support many health claims made about them.」
評級由多源健康證據引擎彙整(FDA/EFSA/NHS/TFDA/WHO/PubMed/NIH ODS 等多個官方與權威來源)。 產製日期 2026-06-01 · 版本 v32。本評級僅供衛教參考,不取代醫師診斷與處方。 · 查看此成分的完整評級 · 📊 證據資料庫原始頁面
白話說:有初步證據,但研究規模還小,別當成定論。
證據分數 59 分(滿分 100) · 發布狀態:可參考,但附帶但書
- US FDA 態度:持保留
展開原文引用
「FDA has not approved any probiotic product for use as a drug or biological product in infants of any age」 - EU EFSA 態度:不支持
展開原文引用
「a cause and effect relationship had not been established between the consumption of a combination of bacterial strains and reduction of gastro-intestinal discomfort」 - UK NHS 態度:持保留
展開原文引用
「There's some evidence that probiotics may be helpful in some cases, such as helping to ease some symptoms of irritable bowel syndrome (IBS). But there's little evidence to support many health claims made about them.」
評級由多源健康證據引擎彙整(FDA/EFSA/NHS/TFDA/WHO/PubMed/NIH ODS 等多個官方與權威來源)。 產製日期 2026-06-08 · 版本 v33。本評級僅供衛教參考,不取代醫師診斷與處方。 · 查看此成分的完整評級 · 📊 證據資料庫原始頁面
白話說:目前沒有可靠的人體研究,無法下定論。
證據分數 54 分(滿分 100) · 發布狀態:證據尚不足以下判斷
- US FDA 態度:持保留
展開原文引用
「FDA has not approved any probiotic product for use as a drug or biological product in infants of any age」 - EU EFSA 態度:不支持
展開原文引用
「a cause and effect relationship had not been established between the consumption of a combination of bacterial strains and reduction of gastro-intestinal discomfort」 - UK NHS 態度:持保留
展開原文引用
「There's some evidence that probiotics may be helpful in some cases, such as helping to ease some symptoms of irritable bowel syndrome (IBS). But there's little evidence to support many health claims made about them.」
評級由多源健康證據引擎彙整(FDA/EFSA/NHS/TFDA/WHO/PubMed/NIH ODS 等多個官方與權威來源)。 產製日期 2026-06-01 · 版本 v32。本評級僅供衛教參考,不取代醫師診斷與處方。 · 查看此成分的完整評級 · 📊 證據資料庫原始頁面
白話說:證據還很薄弱,不足以當成有效的療法。
證據分數 43 分(滿分 100) · 發布狀態:可參考,但附帶但書
- US FDA 態度:持保留
展開原文引用
「FDA has not approved any probiotic product for use as a drug or biological product in infants of any age」 - EU EFSA 態度:不支持
展開原文引用
「a cause and effect relationship had not been established between the consumption of a combination of bacterial strains and reduction of gastro-intestinal discomfort」 - UK NHS 態度:持保留
展開原文引用
「There's some evidence that probiotics may be helpful in some cases, such as helping to ease some symptoms of irritable bowel syndrome (IBS). But there's little evidence to support many health claims made about them.」
評級由多源健康證據引擎彙整(FDA/EFSA/NHS/TFDA/WHO/PubMed/NIH ODS 等多個官方與權威來源)。 產製日期 2026-06-09 · 版本 v9。本評級僅供衛教參考,不取代醫師診斷與處方。 · 查看此成分的完整評級 · 📊 證據資料庫原始頁面